Search for: "Osborne Construction Company" Results 21 - 30 of 30
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2013, 5:13 am by INFORRM
” The legislature wants to “encourage celebrities to visit and reside in our state by creating a civil cause of action for the constructive invasion of privacy. [read post]
20 May 2012, 3:00 am by INFORRM
” He said Mr Jay’s description of a note of the meeting taken by Bernard Ingham, Thatcher’s press secretary at the time, as “carefully constructed” was unjustified and Mr Ingham “would have to be positively dishonest if a deal was admitted from the record”. [read post]
23 Sep 2011, 5:49 pm
At the same time, the company responsible for hiring contractors should also maximize the safety of their workers. [read post]
19 Mar 2010, 5:45 am by sally
Court of Appeal (Civil Division) Sarkar v West London Mental Health NHS Trust [2010] EWCA Civ 289 (19 March 2010) Maroudas v Secretary of State for Environment Food & Rural Affairs [2010] EWCA Civ 280 (18 March 2010) Connor v Surrey County Council [2010] EWCA Civ 286 (18 March 2010) William Hare Ltd v Shepherd Construction Ltd [2010] EWCA Civ 283 (18 March 2010) Bloomsbury International Ltd & Ors. v The Sea Fish Industry Authority & Anor [2010] EWCA Civ 263 (18 March 2010) … [read post]
27 Jan 2010, 6:55 pm by Jim Reed
The scaffolding may have been unstable, Osborne added. [read post]
8 Apr 2009, 11:14 am by Cyrus E. Phillips IV
In Osborne Construction Company, ASBCA No. 55030, February 19th, 2009, the Armed Services Board of Contract Appeals points out the flexibility afforded Agency Boards with the Rule 4 Appeal File, a flexibility which stems from Agency Board ability to rely on the Rule 4 documents and from the discretion given Agency Boards to weigh this documentary evidence. [read post]
26 Sep 2008, 2:37 pm
John Osborne, our Director of Career Counseling and Placement, has a "been there, done that" style. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying… [read post]